HMGB1 and irritable bowel syndrome: In addition, animal studies have shown that HMGB1 production and signalling can be significantly modulated by therapeutic intervention with dipotassium glycyrrhizate [42] or ethyl pyruvate [43] suggesting that such intervention could have a place in human IBD.